#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Colorectal cancer metastatic Obesity Prostate cancer Crohn's disease Colorectal cancer Ovarian cancer Dementia Alzheimer's type Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Anal squamous cell carcinoma Brain abscess Neuroblastoma recurrent Skin angiosarcoma Gastrointestinal stromal tumour Conjunctivitis allergic Endometrial cancer recurrent Spina bifida Splenic marginal zone lymphoma Sickle cell anaemia Post transplant lymphoproliferative disorder Infantile apnoea Squamous cell carcinoma of the vulva Pustular psoriasis Hypochondroplasia More trials…

    Learn about Rare Diseases

    Piriformis syndrome – Diagnostics Angelman’s syndrome Mantle cell lymphoma refractory Focal segmental glomerulosclerosis Atypical teratoid/rhabdoid tumour of CNS – Trials in Disease Arterial tortuosity syndrome Ewing’s sarcoma recurrent – Trials in Disease Acute respiratory distress syndrome – Life with Disease Ehlers-Danlos syndrome – Diagnostics Angiosarcoma – Diagnostics More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Ecoo75 Procarbazine Hydrochloride Damoctocog Alfa Pegol Rineterkib Mercaptopurine Ds-2325A S230815-2 Treprostinil Sodium Ly4100511 GSKVX000000070965 Sufentanil Cobicistat Danazol Bisacodyl Linerixibat Regn7257 Bi 764524 Choriogonadotropin Alfa Everolimus Piperacillin Monohydrate More therapies…

    Learn about Your Condition

    Restless legs syndrome Pancreatic neoplasm White matter lesion Glioma Urea cycle disorder Stevens-Johnson syndrome Pyoderma Hepatic fibrosis Sepsis Cardiac valve disease Venous thrombosis limb Pulmonary vascular disorder Cardiac disorder Papulopustular rosacea Hepatoblastoma More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Nutritional and Metabolic Diseases

  • A study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes not well controlled by diet and exercise

    Not recruiting

    3 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    Hungary Italy Poland

  • A study testing cagrilintide for weight loss in people with overweight or obesity and type 2 diabetes

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    • Overweight
    Investigated Drugs:
    • Cagrilintide
    Croatia Czechia Hungary Romania Slovakia

  • A study testing how well cagrilintide and semaglutide help people with overweight or obesity lose weight

    Not recruiting

    3 1
    Investigated Diseases:
    • Obesity
    Investigated Drugs:
    • Cagrilintide
    • Semaglutide
    France Germany

  • A study testing cagrilintide and semaglutide compared to placebo in people with type 2 diabetes taking basal insulin with or without metformin

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • INSULIN DEGLUDEC
    • Insulin Glargine
    • Metformin Embonate
    Slovakia

  • Study comparing semaglutide and dapagliflozin taken separately or combined in one tablet for type 2 diabetes patients

    Not recruiting

    1 1 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapagliflozin
    • Semaglutide
    Germany

  • Study of oral and injectable NNC0487-0111 (Amycretin) to find the best dose for blood sugar control in adults with type 2 diabetes taking metformin with or without SGLT2 inhibitor

    Not recruiting

    2 1 1
    Investigated Diseases:
    • Type 2 diabetes mellitus
    Investigated Drugs:
    • Dapagliflozin Propanediol
    • Metformin Embonate
    Bulgaria Croatia Germany Greece Hungary Poland +3
Previous Page
1 … 33 34 35 36 37 … 61
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!